Sionna including strong clinical execution across multiple programs. Encouraging interim Phase 1 data for SION-719 and SION-451, our highly potent nucleotide-binding domain 1 stabilizers, showed that ...

Based upon a successful engagement with the US Food and Drug Administration (FDA) at the End-of-Phase 2 meeting in January ...

Clinical data highlight survival benefits and improvement in functional motor outcomes associated with treatment with doxecitine (dC) and ...

Toribio Rodríguez de Mendoza National University researchers conducted a genomic analysis of fine aroma cocoa from northern ...

The polygenic score calculated using concordant single-nucleotide variants may be a method to evaluate risk for alcohol use ...